Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05898919
Other study ID # HCDUTCM_2022056
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date March 1, 2022
Est. completion date July 6, 2023

Study information

Verified date July 2023
Source Chengdu University of Traditional Chinese Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this study is to examine the efficacy of acupuncture in the management of acute postoperative urinary retention. Clinical question: Is acupuncture efficacious for postoperative urinary retention after hemorrhoidectomy compared with sham acupuncture and neostigmine. Study design: The participants who undergo hemorrhoidectomy and report postoperative urinary retention will receive one session of acupuncture or sham acupuncture or one injection of 1-mg neostigmine. The primary outcome was the time to first urination after surgery.


Recruitment information / eligibility

Status Completed
Enrollment 92
Est. completion date July 6, 2023
Est. primary completion date May 25, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Aged between 18 and 65 years - Meets the diagnostic criteria of postoperative urinary retention - Received milligan-morgan hemorrhoidectomy and general anesthesia Exclusion Criteria: - Received Diuretic drugs - Organic diseases that cause urinary retention - Severe infection in the urinary tract - Has a history of adverse reaction to neostigmine - Cognitive dysfunction that affects outcome assessment - Being pregnant

Study Design


Intervention

Other:
Acupuncture
Acupuncture is a technique that inserts a needle into the acupuncture point to treat a condition. In this trial, we will use acupuncture to treat postoperative urinary retention.
Sham acupuncture
Participants will receive sham acupuncture at sham points.
Drug:
Neostigmine Injectable Product
Neostigmine was injected once after postoperative urinary retention.

Locations

Country Name City State
China Hospital of Chengdu University of Traditional Chinese Medicine Chengdu

Sponsors (1)

Lead Sponsor Collaborator
Chengdu University of Traditional Chinese Medicine

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary The time to first urination after surgery This outcome records the time period from the end of surgery to the immediately first urination. Immediately after first urination
Secondary The volume of first of urination This outcome measures the total volume of the first urination after surgery. Immediately after first urination
Secondary Bladder residual urine volume This outcome measures the bladder residual urine volume using the ultrasound measurement. 10 minutes before treatment, 0.5, 1, and 2 hours after treatment.
Secondary Urination Score The urination score ranges from 0 to 4 points. A higher score indicates more difficult to urinate. 10 minutes before treatment, 0.5, 1, and 2 hours after treatment.
Secondary Abdominal symptom score The abdominal symptom score ranges from 0 to 3 points. A higher score indicates worse abdominal symptoms. Before treatment, 0.5, 1, and 2 hours after treatment.
Secondary Visual analogue score after surgery The visual analogue score ranges from 0 to 10 cm. A higher score indicates more painful symptoms. 2 hours after treatment.
Secondary Adverse effects The adverse events will recorded by the patients and evaluated by the physicians. And the adverse events will be classified into mild and severe. Mild adverse events need no additional medical care. 48 hours after treatment
See also
  Status Clinical Trial Phase
Recruiting NCT03181620 - Sedation Administration Timing: Intermittent Dosing Reduces Time to Extubation N/A
Recruiting NCT04205058 - Coffee After Pancreatic Surgery N/A
Completed NCT02565420 - Saline Versus Lactated Ringer's Solution: The SOLAR Fluid Trial N/A
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Completed NCT03662672 - Rib Raising for Post-operative Ileus N/A
Completed NCT03787849 - Epigenetics in PostOperative Pediatric Emergence Delirium N/A
Active, not recruiting NCT05886387 - a Bayesian Analysis of Three Randomised Clinical Trials of Intraoperative Ventilation
Not yet recruiting NCT06351475 - Efficacy of Intraoperative Use of 20% Albumin Combined With Ringer Lactate Versus Ringer Lactate During Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy N/A
Not yet recruiting NCT05052021 - The South African Coronavirus Disease of 2019 (COVID-19) Surgical Outcomes Study
Not yet recruiting NCT03591432 - A Trial Comparing Transnasal humidified Rapid insufflation Ventilatory Exchange (THRIVE) and Apneic Oxygenation With Facemask Ventilation in Elderly Patients Undergoing Induction of Anaesthesia. N/A
Not yet recruiting NCT03639012 - Outcomes of Carbohydrate Loading Paediatric Patients Preoperatively for Tonsillectomy and Adenoidectomy N/A
Not yet recruiting NCT03275324 - Use of Integrated Pulmonary Index to Predict Post-Operative Respiratory Adverse Events in High Risk Patients N/A
Recruiting NCT02763878 - Uncut Roux-en-y Anastomosis Reduce Postoperative Complication and Improve Nutritional Status After Distal Gastrectomy Phase 3
Completed NCT02891187 - Visits Versus Telephone Calls for Postoperative Care N/A
Completed NCT02947789 - Predictive Model for Postoperative Mortality N/A
Completed NCT02766062 - Effects of Propofol and Sevoflurane on Early POCD in Elderly Patients With Metabolic Syndrome N/A
Not yet recruiting NCT02542423 - Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure. N/A
Recruiting NCT01934049 - Postoperative Recovery in Elderly Patients Undergoing Hip Hemi-arthroplasty Phase 4
Enrolling by invitation NCT01744938 - Preoperative Biliary Drainage for the Lower Malignant Obstructive Jaundice Phase 3
Completed NCT02265991 - Prospective Biomechanical Analysis of Donor-site Morbidity Following Microvascular Fibula Transplantation N/A